Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma. - Wikidata - awgldk - TriplyDB

Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.

Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.

http://www.wikidata.org/entity/Q34105623

about

Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.

http://www.wikidata.org/entity/Q34105623

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@ast

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@en

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@nl

type

label

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@ast

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@en

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@nl

prefLabel

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@ast

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@en

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@nl

P1433

Q34105623-415037BD-7C7E-4089-99AD-0452F26641AC

P1476

Q34105623-CCBD1E87-2F75-4D0F-A212-D054A9C702B2

P2093

Q34105623-34035557-A52A-45AF-9F56-7CD9C09D7661

Q34105623-419BE63B-EBFE-4190-94F8-2CE9E1BAFB8C

Q34105623-4323D728-5D0E-4E25-8475-B718798503FC

Q34105623-6D8E42C4-67BC-46F0-A024-7BA5248CE92B

Q34105623-C07080F3-408C-45F6-A299-C706D8A28E5B

Q34105623-E504C86E-9490-4737-B69A-09C414E0396F

Q34105623-EC815D40-CDEB-4F9E-BB8E-6E6BF0074371

P2860

Q34105623-0637C659-2AC2-46A8-8F30-D5E07CA64765

Q34105623-0DE0C0ED-BED2-4400-AF74-CB1054116308

Q34105623-1A133975-D594-46A9-B0D2-7A646AC2962B

Q34105623-21B1EA9E-A27E-46D1-ACE6-3DD192FF1DCF

Q34105623-21C81424-ADAE-4353-A7F9-9E0035187F96

Q34105623-23781CAA-E69F-4C86-A1E3-4B0CF09B00F3

Q34105623-255364F9-E622-4DD4-A826-C161C99D0EF4

Q34105623-39DBDE59-7256-4A2D-882E-8AA46C56E7AE

Q34105623-4A3F50C0-47AC-4AAB-96E0-A7FDD8A2CA06

Q34105623-55FC3D82-F2E1-4F18-B10B-A518DF576226

P304

Q34105623-592310B6-54C0-44BD-8278-DED1FC37CFB6

P31

Q34105623-4C4384F5-3382-4706-BE74-51D241BD2349

P356

Q34105623-C6558F60-CA7D-422B-B966-B5DEB56A7BD6

P433

Q34105623-876982B9-2299-452B-89C8-0A614310E028

P478

Q34105623-6AEB298F-BE46-4744-83AC-CCEC055D8A02

P577

Q34105623-4BB416BF-DC97-4F9F-8697-458C5523EAE6

P698

Q34105623-75D80642-6E96-4992-B0FC-3C8D170A57F1

P932

Q34105623-7DC3658D-DF21-4CFF-9429-CFCDF4CD8B55

P356

PAI.0B013E3182A8D4BB

P1433

Applied Immunohistochemistry & Molecular Morphology

P1476

Comparative evaluation of stra ...... way proteins in Ewing sarcoma.

@en

P2093

Andrew E Horvai

http://www.w3.org/2001/XMLSchema#string

Dafydd G Thomas

http://www.w3.org/2001/XMLSchema#string

Elizabeth R Lawlor

http://www.w3.org/2001/XMLSchema#string

Jon Burrows

http://www.w3.org/2001/XMLSchema#string

Mark A Applebaum

http://www.w3.org/2001/XMLSchema#string

Steven G DuBois

http://www.w3.org/2001/XMLSchema#string

Todd Hembrough

http://www.w3.org/2001/XMLSchema#string

P2860

Children's Oncology Group's 2013 blueprint for research: bone tumors

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.

R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study

Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors.

Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors.

Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.

Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.

Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor

P304

593-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAI.0B013E3182A8D4BB

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24590121

http://www.w3.org/2001/XMLSchema#string

P932

4148473

http://www.w3.org/2001/XMLSchema#string